@article{4a426dde7b314ebcb2ca410444e5c532,
title = "Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab",
author = "Coco Dekkers and \{van der Wal\}, \{M Marlot\} and \{El Amrani\}, Mohsin and \{van Luin\}, Matthijs and Bakker, \{Daphne S\} and \{de Bruin-Weller\}, Marjolein and \{van Wijk\}, Femke",
note = "Funding Information: CD, MMVDW, MEA, MVL, DSB, MDBW, and FVW have made substantial contributions to conception and design, the acquisition of data, or the analysis and interpretation of data. All authors have been involved in drafting the manuscript or revising it critically and have given their final approval of the version to be published. Patients included in this manuscript participated in the BioDay registry sponsored by Sanofi Genzyme. Conceptualization: CD, MMVDW, DSB, MDBW, FVW; Formal Analysis: CD, MMVDW, MEA; Funding Acquisition: FVW, MDBW; Investigation: CD, MMVDW, MEA; Methodology: MMVDW, MEA; Resources: CD, MMVDW, MEA; Supervision: MDBW, FVW; Validation: FVW; Visualization: CD, MMVDW; Writing - Original Draft Preparation: CD, MMVDW; Writing - Review and Editing: MEA, MVL, DSB, MDBW, FVW",
year = "2023",
month = sep,
doi = "10.1016/j.jid.2023.03.1659",
language = "English",
volume = "143",
pages = "1822--1825.e3",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Elsevier",
number = "9",
}